Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient and Long-Term Transgene Expression in the CNS
Open Access
- 13 April 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy - Methods & Clinical Development
- Vol. 17, 843-857
- https://doi.org/10.1016/j.omtm.2020.04.004
Abstract
No abstract availableFunding Information
- Princeton Neuroscience Institute
- NIH (P40OD010996)
This publication has 76 references indexed in Scilit:
- Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse BrainPLOS ONE, 2013
- CTCFBSDB 2.0: a database for CTCF-binding sites and genome organizationNucleic Acids Research, 2012
- Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary VectorsHuman Gene Therapy, 2011
- Retro-orbital injections in miceLab Animal, 2011
- Systematic Comparison of Constitutive Promoters and the Doxycycline-Inducible PromoterPLOS ONE, 2010
- Compartmented Neuron Cultures for Directional Infection by Alpha HerpesvirusesCurrent Protocols in Cell Biology, 2009
- Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promotersGene Therapy, 2009
- Short promoters in viral vectors drive selective expression in mammalian inhibitory neurons, but do not restrict activity to specific inhibitory cell-typesFrontiers in Neural Circuits, 2009
- Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's diseaseGene Therapy, 2002
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999